Year: 2008
Session type: Poster / e-Poster / Silent Theatre session
Ros Eeles1, Zsofia Kote-Jarai1, Douglas Easton2, Janet Stanford3, Elaine Ostrander4, Johanna Schleutker5, Sue Ingles6, Daniel Schaid7, Stephen Thibodeau7, Thilo Dork8, David Neal/ProtecT Group9, Walter Vogel10, Michelle Guy1, Kenneth Muir11, Mary-Anne Kedda12, Esther John13, Graham Giles14, Will Foulkes15, Ali Amin Al Olama2, The PRACTICAL/UKGPCS Group1
1The Institute of Cancer Research, Sutton, UK, 2Strangeways Laboratory, Cambridge, UK, 3Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA, 4National Human Genome Research Institute, National Institutes of Health, Bethesda MD, USA, 5Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland, 6Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles CA, USA, 7Mayo Clinic, Minnesota, USA, 8Hannover Medical School, Hannover, Germany, 9Surgical Oncology, Cambridge Research Institute, Cambridge, UK, 10Institut für Humangenetik, Ulm, Germany, 11University of Nottingham, Nottingham, UK, 12School of Public Health and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia, 13Northern California Cancer Center, Fremont, California, USA and Stanford University School of Medicine, Stanford, California, USA, 14Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia, 15McGill University, Montreal, Canada